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Phosphatidylinositol glycan class A (PIGA) is involved in the first step of glycosylphosphatidylinositol (GPI) biosynthesis. Many
proteins, including CD55 and CD59, are anchored to the cell by GPI. Loss of CD55 and CD59 on erythrocytes causes complement-
mediated lysis in paroxysmal nocturnal hemoglobinuria (PNH), a disease that manifests after clonal expansion of hematopoietic cells
with somatic PIGA mutations. Although somatic PIGA mutations have been identified in many PNH patients, it has been proposed
that germlinemutations are lethal. We report a family with an X-linked lethal disorder involving cleft palate, neonatal seizures, contrac-
tures, central nervous system (CNS) structural malformations, and other anomalies. An X chromosome exome next-generation
sequencing screen identified a single nonsense PIGA mutation, c.1234C>T, which predicts p.Arg412*. This variant segregated with
disease and carrier status in the family, is similar to mutations known to cause PNH as a result of PIGA dysfunction, and was absent
in 409 controls. PIGA-null mutations are thought to be embryonic lethal, suggesting that p.Arg412* PIGA has residual function. Trans-
fection of a mutant p.Arg412* PIGA construct into PIGA-null cells showed partial restoration of GPI-anchored proteins. The genetic data
show that the c.1234C>T (p.Arg412*) mutation is present in an affected child, is linked to the affected chromosome in this family, is rare
in the population, and results in reduced, but not absent, biosynthesis of GPI anchors. We conclude that c.1234C>T in PIGA results in
the lethal X-linked phenotype recognized in the reported family.Phosphatidylinositol glycan class A (PIGA [MIM 311770])
is one of seven proteins involved in the first step of GPI
anchor biosynthesis: transferring N-acetylglucosamine
(GlcNAc) from uridine 50-diphospho N-acetylglucosamide
(UDP-GlcNAc) to PI to form GlcNac-PI.1 Many proteins
are anchored to cells by GPI, and in the absence of GPI
anchors, these proteins are degraded. The loss of CD55
and CD59 on erythrocytes causes complement-mediated
lysis in paroxysmal nocturnal hemoglobinuria (PNH
[MIM 300818]), a disease that manifests after clonal expan-
sion of hematopoietic cells with somatic PIGA muta-
tions.2–5 Although somatic PIGA mutations have been
identified in many patients with PNH, it has been
proposed that germline PIGA mutations are lethal.6,7
Germline mutations in PIGA have never been identified,
but mutations in genes encoding PIGM,8 PIGV,9 and
PIGN,10 proteins involved in GPI-anchor biosynthesis,
have been reported. A promoter mutation in PIGM (MIM
610273) was identified in two families affected by in-
herited glycosylphophatidylinosital deficiency (MIM
610293) that resulted in thrombosis and seizures. Muta-
tions in PIGV (MIM 610274) were identified in four fami-
lies affected by hyperphosphatasia mental retardation
syndrome (HPMR), also known as Mabry syndrome
(MIM 239300). Individuals with Mabry syndrome present
with elevated alkaline phosphatase levels, mental retarda-
tion, seizures, hypotonia, and facial dysmorphism. Lastly,1Genetic Disease Research Branch, National Human Genome Research Institut
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The Americaa missense mutation was identified in PIGN (MIM
606097) in a large consanguineous family affected
by multiple-congenital-anomalies-hypotonia-seizures syn-
drome (MCAHS [MIM 614080]). We identified a nonsense
mutation in PIGA by using X chromosome exome
sequencing in a family with a male-lethal X-linked
disorder. This report both expands the phenotype for
deficiencies of the GPI biosynthesis pathway and more
specifically identifies the phenotype for germline muta-
tions in PIGA.
The family described here presented with three deceased
male children and two obligate carrier females. The
proband (IV-2, Figures 1 and 2) was a male infant and
the second pregnancy of a 33-year-old woman. He was
delivered by Cesarean section secondary to his having
been in the breech position. Prenatal ultrasound showed
a right pelviectasis. Apgar scores were 11 and 7.5 Birth
weight was 3540 g (~75th centile), length was 53.5 cm
(>90th centile), and occipital frontal circumference (OFC)
was 37 cm (>90th centile). He had Pierre Robin sequence;
a prominent occiput; an enlarged fontanelle; a depressed
nasal bridge; a short, anteverted nose; malar flattening; up-
slanted palpebral fissures; an overfolded helix; gingival
overgrowth; a small mouth with downturned corners
and a triangular shape; a short neck (Figure 1A); a globu-
lous chest; and small nails. There was a systolic II–III/VI
murmur with a fixed split S2. He had hip, knee, and elbowe, National Institutes of Health, Bethesda, MD, USA; 2Division of Neurology,
ematology, Department of Internal Medicine, Johns Hopkins University,
mural Sequencing Center, National Human Genome Research Institute,
Genetics. All rights reserved.
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Figure 1. Phenotype of IV-2 and IV-4
(A–C) Individual IV-2. (A) Craniofacial
features including micrognathia, a promi-
nent occiput, a depressed nasal bridge,
a short, anteverted nose, malar flattening,
upslanted palpebral fissures, a small, trian-
gular mouth, downturned corners of
the mouth, and a short neck. (B) Sagittal
T1-weighted cranial MRI demonstrates
thinning of the genu of the corpus cal-
losum, mild sulcal prominence, and cere-
bellar hypoplasia. (C) Axial T1-weighted
MRI demonstrates white-matter or myeli-
nation immaturity for the individual’s age.
(D–F) Individual IV-4. (D) Facial image
showing similar facial features to those of
IV-2. (E) Sagittal T1 cranial MRI demon-
strates a thin corpus callosum, sulcal pro-
minence, and a small cerebellum. (F) Axial
T1-weighted cranial MRI demonstrates
white-matter immaturity.contractures, broad palms with short fingers, and poor
central tone with brisk reflexes.
On evaluation, he had obstructive apnea, an atrial septal
defect, vesicoureteral reflux, and a duplicated collecting
system. Cranial MRI showed a thin corpus callosum,
white-matter immaturity, no septum pellucidum, a dilated
left lateral ventricle, and a small cerebellum (Figures 1B
and 1C). He had myoclonic seizures requiring multiple
medications, and his EEG showed burst suppression.
Ionized calcium was 0.97 mmol/liter (1.13–1.32 mmol/
liter), Hgb was 12.3 g/dl (14.0–18.0 g/dl), RBC was
3.92 M (4.7–6.1 M), MCV was 91.9 fl (80–94 fl), and
RDW was 14.7% (11.5%–14.5%). He lived for about296 The American Journal of Human Genetics 90, 295–300, February 10, 201211 weeks and died from pneumonia.
No autopsy was performed.
Thebrother (IV-4 in Figure2) of indi-
vidual IV-2 was born at 35 weeks.
Prenatal ultrasound showed polyhy-
dramnios. Delivery was by Cesarean
for fetal distress and breech. Apgar
scoreswere1,16,5 and7.10Birthweight
was 3500 g (>90th centile), length was
48 cm (75th–90th centile), and OFC
was 35.5 cm (~97th centile). His
features were similar to those of his
brother (Figure1D).Healsohada fused
metopic suture, a high-arched palate,
and underdeveloped gums. Poor
central tone with brisk reflexes and
contractures were noted with severe
myoclonic seizures.
Additional findings included a
small PDA. Calcium was normal, but
alkaline phosphatase was 412 IU/liter
(39–117 IU/liter). Cranial MRI show-
ed a thin corpus callosum, sulcal
prominence, a small cerebellum, andwhite matter immaturity (Figures 1E and 1F). An EEG
showed a burst suppression pattern. Hgb was 17.3 g/dl,
RBC was 4.74 M, MCV was 103.7 fl, and RDW was 16.2%.
He lived for 10 weeks and died of respiratory failure. The
autopsy showed hepatic microvesicular steatosis and bron-
chopneumonia. Examination of the central nervous
system (CNS) showed dilated superficial vasculature. The
corpus callosum was thin, and the cerebellum was small.
The olfactory bulb and tracts were absent. White matter
appeared dark (reversed cortical ribbon sign) and was
decreased. Microscopically, abnormal cortical lamination
was present. There were many red, ischemic neurons.
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Figure 2. Identification and Segregation of the
PIGA Mutation
(A) Pedigree showing segregation of carrier or
affected status with the presence of the mutation
(þ, wild-type; M, mutant).
(B) Filtering criteria used for identification of the
mutation from a total of 1,360 variants identified
in individual III-2.
(C) Sanger sequence verification; an arrow shows
the position of the mutation.pontis had multiple dysplastic changes. The diagnosis was
hypoxic ischemic encephalopathy and brain malforma-
tion with arhinencephaly. Muscles and bones showed
noted variation in myofibril diameter and trilineage hema-
topoiesis, respectively.
In addition to individuals IV-2 and IV-4, an uncle (III-3
in Figure 2) was reported to have had similar characteris-
tics. The uncle died at one month due to ‘‘stroke.’’ There
are no medical or autopsy records available. Neither obli-
gate carrier female had any of the clinical manifestations
that were seen in the affected males.
The pedigree suggested X-linked inheritance in this
family, and X-chromosome-inactivation studies (Green-
wood Genetics Center) showed the pattern of X inactiva-
tion to be 100% skewed in both obligate carrier females,
supporting X linkage. On the basis of the evidence for
X-linked inheritance, one sample from an obligate carrier
female was included in a sequencing screen of all X exons.
For the purpose of this project, ‘‘X exons’’ were defined
as all exons between positions 2,675,000 bp and
154,500,000 bp of known coding and noncoding genes
in build 36 of the UCSC Genome Browser. We used solu-
tion hybridization for X exons (Sure Select, Agilent, Santa
Clara, CA) to generate a single-end sequencing platform
library (Illumina, San Diego, CA). The X exon oligonucleo-
tide library was designed to select 81.3% of the target. The
library was sequenced on one lane of an Illumina GAII in
single-end 36 bp configuration. The sequencing yieldedThe American Journal of Hum18,509,569 reads. Of these, 52.1% could
be uniquely aligned to the X exome target.
This yielded an overall coverage of 1073.
Coverage was R13 for 80.4% of the X
exome, and 72.9% had R203 coverage.
The MPG genotype-calling software11
made calls on 69.2% of the X exon
sequence. Coding changes were predicted
with custom-designed software.12 We
found 1,271 substitutions and 89 insertions
or deletions.
The genotypes were filtered for several
attributes (Figure 2). We reasoned that the
variant should be severe because it caused
a lethal phenotype in hemizygous males,
so we filtered for nonsynonymous, splice-
site, frame-shift, and stop alleles. We used
heterozygosity because the test subject wasan unaffected female carrier for an X-linked trait. We
sequenced eight control samples by using the same meth-
odology and excluded variants that were present in
multiple samples. Additionally, we filtered against variants
present in dbSNP or the ClinSeq cohort (572 control
individuals).13 This left six variants, including a single
nonsense mutation, c.1234C>T in PIGA (RefSeq accession
number NM_002641.2), which predicts p.Arg412*. This
variant was confirmed in the other individuals by Sanger
sequencing (Figure 2), and mutation status segregated
with disease and carrier status. The maternal grand-
mother (II-2 in Figure 2) was a carrier of c.1234C>T, but
the great-grandmother (I-2) was not. Analyses of marker
GATA175D03, 14 kb telomeric to PIGA, showed that I-2
did not share an allele with her affected great-grandchild
(IV-4). The great-grandfather (I-1) was not available for
testing. We conclude that the mutation most likely arose
in II-2 on the X chromosome inherited from her father.
Additionally, no frameshift, nonsense, or splice-site muta-
tions in PIGA were identified in the eight independent
samples sequenced with the same methodology, 572
samples from the ClinSeq exome cohort13 (the whole-
exome capture included PIGA), or a survey of 208 patients
with X-linked mental retardation.14 The c.1234C>T
p.Arg412* variant found in the family was not identified
in the 1000 Genomes data set.15 Human studies were per-
formed according to an approved human subjects research
protocol.an Genetics 90, 295–300, February 10, 2012 297
Figure 3. Reduced Activity of the p.Arg412*
PIGA Mutant in Restoring Surface Expression of
GPI-Anchored Protein after Transfection into
PIGA-Null Cell Lines
Flow-cytometry analysis showing that cell-
surface expression of CD59, a GPI-anchored
protein, is absent in both LD cells (A, left panel)
and TF1-PNH cells (A, right panel). Seventy-two
hours after transfection, the cells that received
vector expressing wild-type PIGA (pPB-wtPIGA)
significantly upregulated surface CD59 expres-
sion (C) in comparison to those that received
empty vector controls (B). The expression of
mutant PIGA (pPB-mutPIGA) partially restored
the surface expression of CD59 (D).p.Arg412* occurs in the last exon of PIGA and is predicted
to result in a truncated proteinmissing the final C-terminal
109 amino acids. Similar mutations are known to cause
dysfunction of PIGA16 in PNH, and both frame-shift and
nonsense mutations have been identified in the 30 region
of the gene. Together, the genetic data show that the
c.1234C>Tp.Arg412* variant is a severe change in the gene,
is rare in the population, is present in an affected child, and
is linked to the affected chromosome in this family. We
conclude that it caused the phenotype in this family.298 The American Journal of Human Genetics 90, 295–300, February 10, 2012In addition to the genetic data, we studied
the possible functional consequences of
this genetic variant. This was challenging
because of the X inactivation status of the
heterozygous carriers (see above) and the
fact that the affected males were deceased.
We tested the hematopoietic cells of the
mother (III-2) of the two affected individ-
uals for evidence of a small proportion of
cells displaying absent GPI-anchored
proteins. We tested her erythrocytes for
evidence of CD59-negative, glycophorin-
A-positive cells but could find none (data
not shown). We also attempted to deplete
her GPI-positive cells by exposing them to
aerolysin, but this did not allow detection
of any glycophorin-A-positive, CD59-nega-
tive cells (data not shown).
To assess the pathogenicity of the
c.1234C>T (p.Arg412*) mutant, we per-
formed transient transfection experiments
in two previously characterized PIGA-
deficient cell lines (LD17 and TF118) and
compared vectors containing wild-type or
mutant PIGA to empty vectors (Figure 3).
PIGA mRNA was amplified from lympho-
blast RNA (One-Step RT-PCR, QIAGEN),
and products were cloned into a PCR4-
TOPO vector (Invitrogen, Carlsbad, CA). A
single full-length cDNA clone was identi-
fied, and sequence confirmation identifiedthree nonsynonymous alterations that were corrected by
site-directed mutagenesis (Quick Change, Agilent). Addi-
tionally, we removed an EcoRI site for cloning purposes
without altering the predicted amino acid sequence. For
the mutant cDNA, the c.1234C>T mutation was intro-
duced. Wild-type and mutant cDNAs were subcloned
into the EcoRI site of the pPB-Ubc plasmid (Dr. Kosuke
Yusa, Sanger Institute, Cambridge, UK). The resultant
pPB-wtPIGA and pPB-mutPIGA vectors express wild-type
and mutant PIGA, respectively, under the control of
human Ubc promoter. All plasmid constructs were
confirmed by restriction digestion and sequencing.
TheLD17 andTF1-PNHcells18werecultured inRPMI1640
with 10% fetal calf serum (FCS). For TF1 culture, 1 ng/ml
GM-SCF was added to the medium. Transfection of LD
and TF1-PNH cells with 1 mg of PIGA-expression plasmid
or control empty vector was performed with the Nucleofec-
tion Kit V (Lonza, Walkersville, MD). Twenty-four hours
after transfection, the cells were washed with PBS and
cultured in freshRPMI supplementedwith1ng/mlGM-SCF.
Seventy-two hours after transfection, the cells were
collected and washed with PBS before being stained with
CD59 monoclonal antibody (BD Biosciences, Sparks, MD)
for analysis of restoration of surface CD59 expression in
a FACScan cytometer (BD Biosciences). Both wild-type and
mutant PIGA restored cell-surface expression of CD59,
a GPI-anchored protein. However, the percentages of
CD59þ cells and the mean fluorescence intensity (MFI) of
both PIGA-null cell lines were significantly lower when
they were transfected with the c.1234C>T PIGA mutant
than when they were transfected with wild-type PIGA.
Heretofore, germline mutations in PIGA have not been
described in humans and were presumed to be embryonic
lethal on the basis of experiments in mice3 and in both
murine19 and human embryonic stem cells.20 Attempts
to create knock-out mice by traditional methods resulted
in low levels of chimerism and embryonic lethality.21
Pluripotent human embryonic stem cells (hES) deficient
in PIGA are defective in trophoblast formation because
they lack GPI-anchored BMP4 coreceptors.20 The data pre-
sented here are consistent with the hypothesized embry-
onic lethality of null mutations in PIGA and suggest that
residual function of the protein is necessary for fetal devel-
opment. The neonatal lethality seen in this family suggests
that even residual function of PIGA is insufficient for
normal development and survival.
Germline mutations have been described in mannosyl-
transferases in the GPI pathway, supporting an important
role for GPI anchor biosynthesis in development and
homeostasis. A PIGM promoter mutation causing reduced
GPI-linked protein expression was described in two fami-
lies affected by portal- and hepatic-vein thrombosis and
persistent absence seizures.8 Missense PIGV mutations
cause hyperphosphatasia mental retardation syndrome
(HPMR [MIM 239300]).9 Individuals with HPMR have
elevated alkaline phosphatase, a distinct facial gestalt,
and neurological features including seizures, muscular
hypotonia, and intellectual disability. A germline missense
mutation has also been reported in PIGN, encoding GPI
ethanolamine phosphate transferase 1.10 Studies in a
knockout mouse cell line suggest that PIGN is not essential
for surface expression of GPI-anchored proteins22 al-
though surface expression of CD59 in patient fibroblasts
was reduced. The resulting phenotype includes hypotonia,
seizures, and multiple congenital anomalies. There is
overlap among the phenotypes associated with these
disorders and those of affected members of the familyThe Americadiscussed here. Cases 1 and 2 had hypotonia, seizures,
and elevated alkaline phosphatase. No thromboses were
recognized, although their uncle, case 3, reportedly died
from a perinatal stroke. Similar to PIGA p.Arg412*, re-
ported PIGM, PIGV, and PIGN alterations are hypomor-
phic and lead to partial loss of GPI anchor biosynthesis.
Interestingly, hemolytic anemia, the primary characteristic
of PNH, is not reported in patients with PIGM, PIGV, or
PIGN mutations and was not found in the patients re-
ported here. Specifically, the affected patients reported
here did not manifest clinical hemoglobinuria. Unfortu-
nately, the affected individuals in this report died prior to
identification of the causative mutation, and the presence
of CD59-negative erythrocytes could not be assessed.
However, autopsies did not reveal any abnormalities in
the hematopoietic system.
A further understanding of the role of GPI anchors in
development comes from studies of female mice obtained
via a Cre/loxP system targeting Piga in preimplantation
embryos.6 These mice have mosaicism for cells expressing
GPI-anchored proteins due to X-inactivation. The level of
GPI-negative cells in different tissues indicates the impor-
tance of GPI-anchored proteins in those tissues. Heart,
lung, brain, and kidney tissues showed high levels of
GPI-positive cells, suggesting that normal development
of these tissues depends on GPI anchors. The CNS includes
many GPI-anchored proteins, including neural-cell-adhe-
sionmolecules (neural CAMs)23 and glypicans24 important
for neuronal migration. Defects in neuronal migration
cause CNS dysfunction, specifically seizures. We hypothe-
size that the CNS structural anomalies and dysfunction
observed here were caused by reduced function of GPI-
anchored CNS proteins.
The advent of next-generation sequencing technologies
paired with exon capture is allowing rapid discovery in
the area of the genetic etiology of human disease. This
study demonstrates that a single family can be used to iden-
tify the causative mutation for a disease. In a disease in
which the identified alteration is not obviously deleterious,
or in which the function of the affected gene is not well
defined, additional cases might be necessary to allow one
to conclude causation. In the case reportedhere, anonsense
mutation was identified in a well-described gene with
a function that is clearly important to normal hematopoi-
esis and important to both development and survival in
a mouse model.21 This study shows that humans with
severe PIGAmutations can survive to birth, although devel-
opment is aberrant. Understanding the germline pheno-
type of PIGA mutations will allow identification of other
affected families and facilitate better understanding of the
role of PIGA in development and hematopoiesis.Acknowledgments
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